drugset / Trial / NCT01319110
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Specific Aim #1: To determine if levels of CoQ10 are low post-cardiac arrest (CA). We will perform a prospective trial with the primary endpoint of describing the prevalence of low serum CoQ10 levels. Specific Aim #2: To determine if CoQ10 levels in post-CA patients can be increased with the administration of exogenous CoQ10.. We will perform a randomized control trial (RCT) of post-CA patients with the secondary endpoint of comparing CoQ10 levels among those randomized to CoQ10 supplementation vs placebo.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-12-31
- Completion
- 2011-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 200 mg | Other |